aczone
| 5:30PM 9/21/2009
A popular eyelash-enhancing drug's promotional materials are raising eyebrows among federal regulators. The U.S. Food and Drug Administration has warned Allergan (AGN) about what the agency says is misleading information on its website for Latisse, a prescription cosmetic drug that lengthens,...